Close
Nordic 9Nordic 9

Julius Bär Group (investor - Others)

Switzerland
See something wrong or missing? Let us know
Offices:Zurich

Julius Bär Group AG is a medium-sized private banking corporation founded and based in Switzerland.

Average round investment:89.99M USD
Average number per year:1.0
Distribution: 2022 (1)2021 (1)
Portfolio companies: Switzerland SEBA BankUnited Kingdom DnaNudge
Mostly invests in: Switzerland Switzerland (1) Financial Services (1)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Julius Bär Group

Name Criteria
United States Tekla Capital Management
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Pfizer Venture Investments
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Surveyor Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Cleveland Avenue
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom HPE Growth
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Financial Services, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France Jeito Capital
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States OrbiMed Advisors
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Syncona
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States TPG
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Financial Services, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Israel Pontifax Venture Capital
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top